DEF 14A

Company

KIORA PHARMACEUTICALS INC

Filed

April 28, 2016

Period of Report

June 21, 2016

Accession Number

0001144204-16-097076

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →